Search results
Michael Rosenblatt, M.D., is a Senior Advisor at Flagship Pioneering and serves as an independent director on a number of Flagship company boards and provides guidance to Flagship and Flagship companies.
DR. MICHAEL ROSENBLATT. Senior Partner, Flagship Pioneering. Harvard Medical School Board of Fellows. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare.
Michael Rosenblatt, M.D., has held major leadership roles in academia and the biopharmaceutical industry, and currently serves as Senior Partner of Flagship Pioneering in Cambridge, MA. Dr. Rosenblatt was Chief Medical Officer (CMO) for Merck from 2009-2016.
Jul 13, 2016 · About Michael Rosenblatt. Dr. Rosenblatt’s appointment to Flagship marks a new chapter in a storied career in science, academic medicine and clinical research. After receiving his undergraduate degree summa cum laude from Columbia University, Dr. Rosenblatt earned his M.D. magna cum laude from Harvard.
Michael Rosenblatt, MD ’73. Senior Advisor, Ascenta Capital; Senior Advisor, Bain Capital Life Sciences; Senior Advisor, Flagship Pioneering.
Sep 29, 2016 · Michael Rosenblatt, newly appointed Chief Medical Officer of Flagship Ventures and former Chief Medical Officer at Merck & Co., discusses his move from industry to venture capital.
Chief Medical Officer Flagship Ventures. Biography. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare. He currently serves as an advisor to the biopharmaceutical industry and academia.
